Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 25128512)

1.

Predictors of incident depression in systemic lupus erythematosus.

Huang X, Magder LS, Petri M.

J Rheumatol. 2014 Sep;41(9):1823-33. doi: 10.3899/jrheum.140111. Epub 2014 Aug 15.

PMID:
25128512
2.

Malignancies in systemic lupus erythematosus: a 2015 update.

Goobie GC, Bernatsky S, Ramsey-Goldman R, Clarke AE.

Curr Opin Rheumatol. 2015 Jun 26. [Epub ahead of print]

PMID:
26125105
3.

Preclinical lupus.

Bourn R, James JA.

Curr Opin Rheumatol. 2015 Jun 26. [Epub ahead of print]

PMID:
26125103
4.

207 Structural basis of the effect of systemic lupus erythematosus (SLE)-associated mutations on the activity of NADPH oxidase.

Armstrong DL, Eisenstein M, Zidovetzki R, Jacob CO.

J Biomol Struct Dyn. 2015 May;33 Suppl 1:139-40. doi: 10.1080/07391102.2015.1038136. No abstract available.

PMID:
26103417
5.
6.

[Depression as a common complication of systemic lupus erythematosus].

Lemaire B, Geron D, Malaise O, Krzesinski JM, Ansseau M, Scantamburlo G.

Rev Med Liege. 2015 Apr;70(4):215-8. French.

PMID:
26054174
7.

Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.

Ruiz-Arruza I, Barbosa C, Ugarte A, Ruiz-Irastorza G.

Autoimmun Rev. 2015 Jun 1. pii: S1568-9972(15)00119-6. doi: 10.1016/j.autrev.2015.05.011. [Epub ahead of print] Review.

PMID:
26044819
8.

Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus.

Wu Y, Zhang F, Ma J, Zhang X, Wu L, Qu B, Xia S, Chen S, Tang Y, Shen N.

Arthritis Res Ther. 2015 May 21;17:131. doi: 10.1186/s13075-015-0632-3.

9.

Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort.

Arroyo-Ávila M, Santiago-Casas Y, McGwin G Jr, Cantor RS, Petri M, Ramsey-Goldman R, Reveille JD, Kimberly RP, Alarcón GS, Vilá LM, Brown EE.

Clin Rheumatol. 2015 Jul;34(7):1217-23. doi: 10.1007/s10067-015-2941-y. Epub 2015 Apr 22.

PMID:
25896533
10.

[Therapeutic strategies for systemic lupus erythematosus].

Schneider M.

Z Rheumatol. 2015 Apr;74(3):199-205. doi: 10.1007/s00393-014-1457-1. German.

PMID:
25854154
11.

Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study.

Merayo-Chalico J, Apodaca E, Barrera-Vargas A, Alcocer-Varela J, Colunga-Pedraza I, González-Patiño A, Arauz A, Abud-Mendoza C, Martínez-Martínez M, Gómez-Martín D.

J Neurol Neurosurg Psychiatry. 2015 Mar 24. pii: jnnp-2014-310145. doi: 10.1136/jnnp-2014-310145. [Epub ahead of print]

PMID:
25804426
12.

Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program.

Housey M, DeGuire P, Lyon-Callo S, Wang L, Marder W, McCune WJ, Helmick CG, Gordon C, Dhar JP, Leisen J, Somers EC.

Am J Public Health. 2015 May;105(5):e74-9. doi: 10.2105/AJPH.2014.302423. Epub 2015 Mar 19.

PMID:
25790387
13.

Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V.

Arthritis Rheumatol. 2015 Jul;67(7):1837-47. doi: 10.1002/art.39111.

PMID:
25778456
14.

Predictors of kidney disease in a cohort of pediatric patients with lupus.

Sule SD, Moodalbail DG, Burnham J, Fivush B, Furth SL.

Lupus. 2015 Jul;24(8):862-8. doi: 10.1177/0961203315570162. Epub 2015 Feb 12.

PMID:
25680740
15.

Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.

Rúa-Figueroa Í, Richi P, López-Longo FJ, Galindo M, Calvo-Alén J, Olivé-Marqués A, Loza-Santamaría E, Vicente SP, Erausquin C, Tomero E, Horcada L, Uriarte E, Sánchez-Atrio A, Rosas J, Montilla C, Fernández-Nebro A, Rodríguez-Gómez M, Vela P, Blanco R, Freire M, Silva L, Díez-Álvarez E, Ibáñez-Barceló M, Zea A, Narváez J, Martínez-Taboada V, Marenco JL, de Castro MF, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas JJ, Pecondón Á, Marras C, Carreira P, Bonilla G, Torrente V, Castellví I, Alegre J, Moreno M, Raya E, de la Peña PG, Vázquez T, Aguirre Á, Quevedo V, Pego-Reigosa JM; EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology).

Medicine (Baltimore). 2015 Jan;94(1):e267. doi: 10.1097/MD.0000000000000267.

PMID:
25569641
16.

Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study.

Faezi ST, Hoseinian AS, Paragomi P, Akbarian M, Esfahanian F, Gharibdoost F, Akhlaghi M, Nadji A, Jamshidi AR, Shahram F, Nejadhosseinian M, Davatchi F.

Mod Rheumatol. 2015 Jul;25(4):590-4. doi: 10.3109/14397595.2014.987366. Epub 2014 Dec 22.

PMID:
25528860
17.
18.

Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?

Catoggio LJ, Soriano ER, Imamura PM, Wojdyla D, Jacobelli S, Massardo L, Chacón Díaz R, Guibert-Toledano M, Alvarellos A, Saurit V, Manni JA, Pascual-Ramos V, Silva de Sauza AW, Bonfa E, Tavares Brenol JC, Ramirez LA, Barile-Fabris LA, De La Torre IG, Alarcón GS, Pons-Estel BA; Grupo Latino Americano De Estudio del Lupus (GLADEL).

Lupus. 2015 Jul;24(8):788-95. doi: 10.1177/0961203314563134. Epub 2014 Dec 11.

PMID:
25504653
19.

Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.

Castrejón I, Tani C, Jolly M, Huang A, Mosca M.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-85-95. Epub 2014 Oct 30. Review.

PMID:
25365095
20.

Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.

Yee CS, Su L, Toescu V, Hickman R, Situnayake D, Bowman S, Farewell V, Gordon C.

Rheumatology (Oxford). 2015 May;54(5):836-43. doi: 10.1093/rheumatology/keu412. Epub 2014 Oct 15.

PMID:
25323056
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk